Skip to content
News Heater
  • Home
  • Business
  • Companies
  • Hot Stocks
  • Trending

AnaptysBio Inc

Analyzing the Price-to-Earnings Ratio of AnaptysBio Inc (ANAB)

February 13, 2026 by Melissa Arnold

The 36-month beta value for ANAB is also noteworthy at 0.35. There are mixed opinions on the stock, with 9 analysts rating it as a “buy”, 3 rating it as “overweight”, 1 rating it as “hold”, and 0 rating it as “sell”. The public float for ANAB is 25.82M, and at present, short sellers hold … Read more

Categories Hot Stocks Tags ANAB, ANAB stock, AnaptysBio Inc, NASDAQ:ANAB

Recent Posts

  • 3 Stocks Showing Steady Market Action: Biodexa Pharmaceuticals (BDRX), Cardiol Therapeutics (CRDL), Basel Medical Group (BMGL)
  • 3 Stocks Showing Ongoing Activity: Cardiol Therapeutics (CRDL), Seer (SEER), BioCardia (BCDA)
  • 3 Stocks That Could Enter Focus Soon: Nortech Systems (NSYS), Cardiol Therapeutics (CRDL), Tvardi Therapeutics (TVRD)
  • 3 Stocks Worth Watching in Real Time: Cardiol Therapeutics (CRDL), Aclarion (ACON), Harvard Bioscience (HBIO)
  • 3 Stocks Worth Watching for Signals: Alzamend Neuro (ALZN), Cardiol Therapeutics (CRDL), Sensei Biotherapeutics (SNSE)

Recent Comments

No comments to show.

About US

NewsHeater specializes in investments in the tech sphere. Its specialists are interested in stocks that are undervalued for various reasons. They are trying to find them, count their potential, and bring them to their clients.

Categories

  • Business
  • Companies
  • Hot Stocks
  • Trending

Quick Links

  • About Newsheater
  • Contact US
  • Disclaimer
  • Privacy Policy
© 2026 News Heater • Built with GeneratePress